How does DKSC's PB Ratio compare to its peers?

Insufficient data to calculate DKSC's Price-To-Book Ratio vs. peers for valuation analysis.

How does DKSC's PB Ratio compare vs other companies in the US Pharmaceuticals Industry?

Insufficient data to calculate DKSC's Price-To-Book Ratio vs. industry for valuation analysis.

What is DKSC's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate DKSC's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of DKSC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate DKSC's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

DKSC Stock Overview

Through its subsidiaries, operates as a CBD/cannabis-based medical product company. More details

DKSC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap ($4M)

Highly volatile share price over the past 3 months compared to the US market

Shareholders have been diluted in the past year

My Notes

Capture your thoughts, links and company narrative

Dakshidin Corporation, Inc. Competitors

China Pharma Holdings

NYSEAM:CPHI

US$4.2m

Enveric Biosciences

NasdaqCM:ENVB

US$4.0m

Artelo Biosciences

NasdaqCM:ARTL

US$3.7m

Petros Pharmaceuticals

NasdaqCM:PTPI

US$3.8m

Price History & Performance

Summary of share price highs, lows and changes for Dakshidin Corporation
Historical stock prices
Current Share Price	US$0.001
52 Week High	US$0.0018
52 Week Low	US$0.0002
Beta	0
1 Month Change	-23.08%
3 Month Change	-9.09%
1 Year Change	100.00%
3 Year Change	-56.52%
5 Year Change	66.67%
Change since IPO	-99.98%

Recent updates

Shareholder Returns

	DKSC	US Pharmaceuticals	US Market
7D	5.3%	0.5%	-2.1%
1Y	100.0%	2.3%	21.3%

Return vs Industry: DKSC exceeded the US Pharmaceuticals industry which returned 2.3% over the past year.

Return vs Market: DKSC exceeded the US Market which returned 21.3% over the past year.

Price Volatility

Is DKSC's price volatile compared to industry and market?
DKSC volatility
DKSC Average Weekly Movement	24.5%
Pharmaceuticals Industry Average Movement	11.1%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: DKSC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: DKSC's weekly volatility has decreased from 31% to 25% over the past year, but is still higher than 75% of US stocks.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Chris Haigh	n/a

Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments.

Dakshidin Corporation, Inc. Fundamentals Summary

How do Dakshidin Corporation's earnings and revenue compare to its market cap?
DKSC fundamental statistics
Market cap	US$4.48m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is DKSC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DKSC income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did DKSC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/12 01:19
End of Day Share Price	2025/01/10 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dakshidin Corporation, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Dakshidin Corporation OTCPK:DKSC Stock Report